IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 51.963
EU - Europa 32.555
AS - Asia 26.463
SA - Sud America 5.387
AF - Africa 657
OC - Oceania 140
Continente sconosciuto - Info sul continente non disponibili 110
Totale 117.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 49.036
SG - Singapore 9.635
GB - Regno Unito 7.253
RU - Federazione Russa 7.236
IT - Italia 6.901
CN - Cina 6.621
BR - Brasile 4.206
VN - Vietnam 3.653
UA - Ucraina 2.332
DE - Germania 2.306
CA - Canada 2.224
HK - Hong Kong 1.964
BD - Bangladesh 1.674
DK - Danimarca 1.529
FR - Francia 1.117
FI - Finlandia 840
SE - Svezia 819
IN - India 566
IE - Irlanda 549
PL - Polonia 537
MX - Messico 474
AR - Argentina 434
NL - Olanda 379
TR - Turchia 327
IL - Israele 279
ID - Indonesia 248
EC - Ecuador 216
IQ - Iraq 214
ZA - Sudafrica 212
PK - Pakistan 209
JP - Giappone 204
ES - Italia 185
CO - Colombia 137
AT - Austria 114
VE - Venezuela 113
EU - Europa 106
AU - Australia 104
UZ - Uzbekistan 100
MA - Marocco 99
SA - Arabia Saudita 90
CL - Cile 86
KR - Corea 76
AE - Emirati Arabi Uniti 69
PY - Paraguay 67
IR - Iran 66
KE - Kenya 64
MY - Malesia 64
LT - Lituania 62
EG - Egitto 61
PH - Filippine 61
PE - Perù 55
TN - Tunisia 52
RO - Romania 48
JO - Giordania 46
CH - Svizzera 41
DZ - Algeria 41
BE - Belgio 40
NP - Nepal 38
CR - Costa Rica 37
JM - Giamaica 37
BO - Bolivia 33
NZ - Nuova Zelanda 33
UY - Uruguay 33
SK - Slovacchia (Repubblica Slovacca) 32
AZ - Azerbaigian 31
HN - Honduras 31
CZ - Repubblica Ceca 30
ET - Etiopia 30
TH - Thailandia 30
PT - Portogallo 27
KZ - Kazakistan 23
TW - Taiwan 22
GR - Grecia 21
DO - Repubblica Dominicana 19
TT - Trinidad e Tobago 19
KG - Kirghizistan 18
PS - Palestinian Territory 17
AL - Albania 16
HU - Ungheria 16
OM - Oman 16
NI - Nicaragua 15
PA - Panama 15
QA - Qatar 15
GE - Georgia 13
GT - Guatemala 13
AM - Armenia 12
LV - Lettonia 12
RS - Serbia 12
BY - Bielorussia 11
NO - Norvegia 11
SN - Senegal 11
BG - Bulgaria 10
BH - Bahrain 10
CI - Costa d'Avorio 10
KW - Kuwait 10
LB - Libano 10
MK - Macedonia 10
SV - El Salvador 10
BA - Bosnia-Erzegovina 9
HR - Croazia 9
Totale 117.078
Salva come PNG Salva come JPEG
Città #
Dallas 8.059
Southend 4.837
Singapore 4.817
San Jose 3.007
Ashburn 2.992
Beijing 2.740
Woodbridge 2.675
Chandler 2.320
Ann Arbor 2.295
Houston 2.108
Hong Kong 1.745
Fairfield 1.626
San Mateo 1.470
Moscow 1.304
Falls Church 1.263
Jacksonville 1.107
Seattle 1.093
Los Angeles 1.052
Dearborn 1.020
Ho Chi Minh City 995
Milan 992
Cambridge 967
Wilmington 895
Ottawa 865
The Dalles 794
New York 754
Rome 664
Chicago 652
Pisa 645
Hanoi 628
Hefei 542
Boardman 539
Santa Clara 524
Dublin 522
Lauterbourg 513
Stevenage 512
Portsmouth 502
Warsaw 492
Dong Ket 483
São Paulo 441
Buffalo 436
Helsinki 426
Montréal 403
Lawrence 385
Council Bluffs 358
Brooklyn 321
Beauharnois 315
London 257
Tel Aviv 251
Munich 247
Orem 244
Salt Lake City 229
Mexico City 212
Montreal 204
Florence 203
Frankfurt am Main 181
San Diego 176
Redwood City 175
Tokyo 165
Old Bridge 158
Denver 155
Stockholm 152
Chennai 150
Columbus 149
Istanbul 148
Rio de Janeiro 144
Toronto 144
Atlanta 143
Poplar 141
Figino 140
Amsterdam 134
Da Nang 134
Johannesburg 134
Phoenix 127
Haiphong 120
Tampa 114
Elk Grove Village 112
Fremont 111
Boston 109
Nuremberg 108
Turin 103
Naples 101
Manchester 95
Bologna 90
Tashkent 90
San Francisco 88
Ankara 78
Biên Hòa 74
Mumbai 73
Belo Horizonte 72
Washington 72
Brasília 71
Curitiba 71
Turku 69
Baghdad 68
Norwalk 68
Shanghai 68
Guayaquil 67
Paris 66
Quito 66
Totale 71.016
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.704
Value in Healthcare and the Role of the Patient Voice 1.202
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 696
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 617
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 598
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 506
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 500
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 487
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 481
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 450
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 436
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 417
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 397
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 392
A simple echocardiographic score to rule out cardiac amyloidosis 388
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 381
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 368
Human pathophysiological adaptations to the space environment 361
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 359
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 356
A simple echocardiographic score to rule out cardiac amyloidosis 354
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 354
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 348
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 344
La neuropatia diabetica 342
The evolution of TAVI performance overtime: an overview of systematic reviews 337
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 336
[Central apneas and cardiovascular diseases] 335
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 334
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 333
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 331
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 331
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 331
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 331
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 330
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 330
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 326
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 326
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 326
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 325
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 325
Treating chemoreflex in heart failure: modulation or demolition? 324
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 324
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 324
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 323
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 323
Prediction of the chemoreflex gain by common clinical variables in heart failure 323
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 322
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 316
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 316
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 315
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 314
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 314
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 314
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 311
Adrenergic activation in heart failure: blockade or rebalance? 309
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 309
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 307
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 306
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 305
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 304
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 303
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 303
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 302
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 302
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 301
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 300
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 300
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 299
Eligibility for vericiguat in a real‐world, contemporary heart failure population 299
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 299
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 298
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 297
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 297
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 295
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 293
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 291
Screening the health status of people working in a university 290
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 290
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 290
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 290
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 289
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 287
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 286
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 286
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 286
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 285
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 285
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 285
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 285
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 284
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 283
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 283
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 281
How to take arms against central apneas in heart failure 281
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 281
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 280
Sex-related differences in chronic heart failure 280
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 278
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 278
Totale 35.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 576.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 576.133
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.353 0 0 0 0 0 0 0 0 0 0 0 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/202651.126 2.676 8.082 5.678 6.166 5.331 3.021 5.769 2.122 2.720 3.260 3.163 3.138
Totale 117.936